SCHEMBL7286587

SCHEMBL7286587

O=C(O)C1OC1c1ccc2c(c1)OCO2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK9 P45984 2/20 0.57
MAPK1 P28482 2/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPT P10636 5/20 0.53
CYP3A4 P08684 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
TRPM8 Q7Z2W7 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
HPGD P15428 1/20 0.53
MCL1 Q07820 1/20 0.53
KDM4E B2RXH2 1/20 0.51
POLB P06746 1/20 0.51
EDNRB P24530 1/20 0.51
EDNRA P25101 1/20 0.51
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CTNNB1 P35222 1/20 0.48
WNT3A P56704 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31454786 0.82 MAPK9 (0.55) MAPK9MAPK1MAPTCYP3A4SMN1; SMN2
SCHEMBL30259745 0.77 MAPT (0.54) MAPK9MAPK1ALDH1A1MAPTCYP3A4
SCHEMBL24564668 0.74 MAPT (0.60) MAPK9MAPK1ALDH1A1MAPTCYP3A4
SCHEMBL15091391 0.74 MAPT (0.60) MAPK9MAPK1ALDH1A1MAPTCYP3A4
SCHEMBL1260710 0.74 MAPK9 (0.77) MAPK9MAPK1MAPTCYP3A4SMN1; SMN2
SCHEMBL7942478 0.74 EDNRA (0.79) EDNRBEDNRA
SCHEMBL7943708 0.74 EDNRA (0.79) EDNRBEDNRA
SCHEMBL7942483 0.74 EDNRA (0.79) EDNRBEDNRA
SCHEMBL4737162 0.73 MAPK9 (1.00) MAPK9MAPK1MAPTCYP3A4SMN1; SMN2
SCHEMBL29477291 0.73 MAPK9 (1.00) MAPK9MAPK1MAPTCYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353032-B1 1,5-BENZOTHIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS Sankyo Company Limited (JP) 1992-02-26 EP disclosed
US-5002942-A Calcium channel blockers for cardiovascular disorders SANKYO COMPANY, LIMITED (JP) 1991-03-26 US disclosed